Advertisement
  • Drug Costs and Cancer Care

    Experts discuss the value of cancer treatments in a climate of rising drug prices.

    by Kevin McLaughlin

  • What Is Hyper-Progression?

    Some researchers believe that immunotherapy occasionally causes cancer to grow faster, a phenomenon dubbed hyper-progression.

    by Kate Yandell

  • Risk Reduction, Clinical Trials Are Focus of Atlanta Community Event

    Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.

    by Kevin McLaughlin

  • March 29: The Week in Cancer News

    Jury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.

    by Marci A. Landsmann

  • Forward Look

    Lynch Syndrome Linked to More Cancers

    Study findings suggest patient screening has been too narrow.

    by Sharon Tregaskis

  • Forward Look

    For Cancer Researchers, Dogs Offer Clues to Help Kids

    Similarities between cancers create path for studying new treatments.

    by Cameron Walker

  • Forward Look

    What’s Next?

    Reducing chemotherapy side effects with a ‘drug sponge.'

    by Bradley Jones

  • Policy Matters

    Eliminating HPV-Related Cancer

    HPV vaccination and screening can help eradicate cervical cancer and other malignancies.

    by Anna R. Giuliano, PhD

  • Keeping an Eye on Cancer

    Imaging tests for post-treatment surveillance may come with radiation exposure, financial strain, “scanxiety” and sometimes unnecessary follow-ups. Doctors and patients need to balance the risks and benefits of scanning.

    by Charlotte Huff

  • More Options for Rare Cancers

    Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.

    by Kendall K. Morgan